|
Dr. Keith March is the chief medical advisor of Cell Therapy Foundation. Dr. March serves as a professor of medicine, physiology and biomedical engineering for the Indiana University School of Medicine and the Krannert Institute of Cardiology.
He is the director of the Indiana Center for Vascular Biology and Medicine as well as director of the IUPUI “Signature” Vascular and Cardiac Center of Adult Stem Cell Cast (VC-CAST). Dr. March has published more than 75 manuscripts and edited the first book dedicated to cardiovascular gene transfer. He has served as a scientific advisor to numerous pharmaceutical, biotechnology, and medical device companies.
Dr. March is committed to bringing new medical approaches to patients. He invented and patented a device called Closer, a suture-mediated closure device that is used to close the arterial hole following a heart catheterization. This device allows a patient to "walk off the table" after a catheterization without requiring prolonged bed rest. Abbott Vascular, an affiliate of Abbott Laboratories, acquired the company that developed this technology in 1999 and the Closer approach is now used in 500,000 patients worldwide annually. His research has resulted in more than 40 worldwide (19 U.S.) patents, with others pending. |
